• THE GROUP
    • Nucleus Holding II
    • Nucleus Management
    • Nucleus Life
    • TriCap Assurance
    • TEAM OF EXPERTS
    • NUCLEUS TEAM
  • SOLUTIONS
    • Asset Protector
    • Nucleus Fund Life
    • Tailor-Made Solutions
    • LIECHTENSTEIN
    • LUXEMBOURG
  • NEWS
  • CONTACT
  • THE GROUP
    • Nucleus Holding II
    • Nucleus Management
    • Nucleus Life
    • TriCap Assurance
    • TEAM OF EXPERTS
    • NUCLEUS TEAM
  • SOLUTIONS
    • Asset Protector
    • Nucleus Fund Life
    • Tailor-Made Solutions
    • LIECHTENSTEIN
    • LUXEMBOURG
  • NEWS
  • CONTACT

NEWS

News, press releases and hand picked insight

Joint Press Release - For immediate release
March 27, 2020  -   4 min read

Photonike Capital SA – Nucleus Holding II SCS:
new acquisitions and effect of Coronavirus

 

Photonike Capital SA (Euronext Access Symbol: MLPHO - Brussels) and Nucleus Holding II SCS (Luxembourg) announced today that they have enlarged the Joint Venture agreement signed on

November 2019.

 

The purpose is to put beside Nucleus Life AG, a life office in operation since 2006, the life insurance company TriCap Assurance SPC in operation since 2007 in the B2B Life Insurance market, exclusively offering “contrats dédiés” (wrappers) to High Net Worth Individuals.

 

The total investment of 10 million euros for the Project is fully financed by Photonike Capital SA using its own resources.

 

The consideration paid includes the possibility of converting the investment into shares of the various investments.

 

Thanks to the new acquisition the group reach over 1,3 billion Euro AUM and a several highly

experienced managers joints the Nucleus family.

 

The joint venture will focus on both top ten worldwide life insurance markets, offering to mass affluent and upper mass affluent customers a suite of innovative unit linked products to meet the investment diversification needs arising from a context of low interest rates.

 

As the World life insurance market is reaching an unprecedented turning point due to the most severe crisis the world has experienced, Photonike Capital SA and Nucleus Holding II SCS are willing to promote new business opportunities in conjunction with an existing distribution network of over 70 brokers and financial advisors and to add over 1,4 billion Euro AUM at the end of the fourth year to the current activities of the group.

 

Fausto M. Ventriglia, president and founder of Photonike Capital SA said that “in Italy, the distribution remains confident in the future, and the Agreement also provides that the distribution will be enforced with the implementation of DLT (Distributed Ledger Technology)/Crypted IT platform for remote subscription and long-term conservation of the contracts”.

 

Vincent Derudder, CEO of Nucleus Holding II SCS expressed “great satisfaction with the agreement

because it allows strong industry, product design and distribution synergies in the coverage of the

insurance risk”.

 

Both also praised the excellent experience and ability of the managers involved in the project supported by the positive message received from the representatives of the industry such as David Charlet, Chairman of FECIF, the 300,000-strong intermediaries trade association stating that “we will all need to be adaptable, resolute, and particularly conscious of society and others, not just ourselves. Focusing on “us” and “we” rather than “I” and “me” is imperative”.

 

Photonike Capital SA (Belgium) and Nucleus Holding II SCS (Luxembourg) inform that the operational activities of Nucleus Life AG have not been slowed down by the Coronavirus epidemic. The company provided for IT infrastructure dedicated to financial advisors and customers, with specific webinars on the products offered with more then 100 participants per time. Thanks to the organization, support is provided to producers and policy subscriptions have not undergone substantial slowdowns.

 

More details:

Madelaine Hellemans

mjh@nucleus.lu

 

Claude Chapelnote

info@photonike.com

 

Related articles

Selected news articles and Press:

JANUARY 2021

Investment Letter January 2021 - Global Market Review 2021

2020 has been difficult in many ways, involving health scares, lifestyle changes and sadness for too many people.  
But in one important way, however, 2020 has been a good year with a powerful rally for US stocks, less for European stocks that.. 

Read article

AUGUST 2020

Investment Letter (July – August 2020) - Global Stocks and the Economy

The news continues to be overwhelming and devastating. Deaths from Covid-19 in the United States have moved above the 135.000 people, nearly 50 million Americans have filed for...

Read article

MARCH 2020

PR: Nucleus Holding II SCA has entered into a Joint Venture with Photonike Capital SA

Photonike Capital SA (Euronext Access Symbol: MLPHO - Brussels) and Nucleus Holding II SCS (Luxembourg) announced today that they have enlarged...

Read article
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
Cookie settingsACCEPT
Manage consent

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary
Always Enabled
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Non-necessary
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
SAVE & ACCEPT